• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Halobenzoic acids and derivatives

N-Ethyl 4-bromo-3-nitrobenzamide (CAS No. 1096291-52-9): A Comprehensive Overview in Modern Chemical Biology

N-Ethyl 4-bromo-3-nitrobenzamide, identified by its CAS number 1096291-52-9, is a significant compound in the realm of chemical biology and pharmaceutical research. This compound, characterized by its unique structural and chemical properties, has garnered considerable attention due to its potential applications in drug discovery and molecular studies. The presence of both bromine and nitro substituents in its molecular framework imparts distinct reactivity, making it a valuable scaffold for synthesizing more complex molecules.

The< strong>N-Ethyl 4-bromo-3-nitrobenzamide molecule exhibits a benzamide core, which is a well-documented pharmacophore in medicinal chemistry. The benzamide group is known for its role in modulating various biological pathways, including pain perception, inflammation, and neurotransmitter activity. The introduction of an ethyl group at the nitrogen position enhances the solubility and bioavailability of the compound, facilitating its use in biochemical assays and drug formulations.

Recent advancements in the field of chemical biology have highlighted the importance of halogenated aromatic compounds in developing novel therapeutic agents. The bromine substituent at the 4-position of the benzene ring in N-Ethyl 4-bromo-3-nitrobenzamide allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing biaryl structures, which are prevalent in many bioactive molecules.

The nitro group at the 3-position adds another layer of reactivity to the molecule. Nitroaromatics are known for their ability to participate in redox reactions, which can be exploited in designing prodrugs or activation mechanisms that release active pharmaceutical ingredients under specific physiological conditions. This characteristic makes N-Ethyl 4-bromo-3-nitrobenzamide a promising candidate for developing smart drug delivery systems.

In the context of drug discovery, N-Ethyl 4-bromo-3-nitrobenzamide has been investigated for its potential as an intermediate in synthesizing kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is associated with various diseases, including cancer. By modifying the structure of N-Ethyl 4-bromo-3-nitrobenzamide, researchers aim to develop selective kinase inhibitors that can modulate these pathways effectively.

Moreover, the compound's ability to serve as a precursor for more complex molecules has been leveraged in the synthesis of antimicrobial agents. The structural features of N-Ethyl 4-bromo-3-nitrobenzamide allow for the introduction of additional functional groups that can enhance antimicrobial activity. This is particularly relevant in an era where antibiotic resistance is becoming increasingly prevalent, necessitating the development of novel antimicrobial strategies.

Recent studies have also explored the use of N-Ethyl 4-bromo-3-nitrobenzamide in materials science applications. The compound's unique electronic properties make it suitable for use in organic semiconductors and light-emitting diodes (OLEDs). By integrating this molecule into materials designed for optoelectronic applications, researchers aim to improve device performance and energy efficiency.

The synthesis of N-Ethyl 4-bromo-3-nitrobenzamide involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as flow chemistry and microwave-assisted synthesis, have been employed to optimize yield and purity. These techniques not only enhance efficiency but also reduce waste, aligning with green chemistry principles.

In conclusion, N-Ethyl 4-bromo-3-nitrobenzamide (CAS No. 1096291-52-9) is a versatile compound with significant implications in chemical biology and pharmaceutical research. Its unique structural features and reactivity make it a valuable tool for developing novel therapeutic agents, biomaterials, and advanced materials. As research continues to uncover new applications for this compound, its importance in modern science is likely to grow even further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)